Efficacy and trial effectiveness of weekly and daily iron supplementation among pregnant women in rural Bangladesh: Disentangling the issues

Eva Charlotte Ekström, S. M Ziauddin Hyder, A. Mushtaque R Chowdhury, Sadia A. Chowdhury, Bo Lönnerdal, Jean Pierre Habicht, Lars Åke Persson

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Background: According to our current understanding, iron absorption with weekly iron supplements is not higher than that with daily supplements (ie, there is no mucosal block). However, community-based trials have repeatedly shown that a weekly regimen is as effective as a daily one. Furthermore, when differences in absorption are found, they are commonly smaller than would be expected on the basis of differences in the amount of iron provided. The possibility of differential compliance between the regimens needs to be evaluated to explain these findings. Objective: Taking compliance into account, we compared the efficacy and trial effectiveness of weekly and daily iron supplementation during pregnancy. Design: In Bangladesh, 50 antenatal centers were randomly assigned to prescribe either 2 doses of 60 mg Fe once weekly or 1 dose of 60 mg Fe/d. Compliance was monitored by using a pill bottle equipped with an electronic counting device. Hemoglobin concentrations were measured at baseline and after 4, 8, and 12 wk of supplementation. Results: There was no differential effect per iron tablet between weekly and daily regimens. A 12-wk daily regimen (68% compliance) produced a small but significantly greater hemoglobin response than did the weekly regimen (104% compliance). The first 20 tablets consumed produced most of the effect; after 40 tablets, there was no further response. Conclusions: There was no evidence of a mucosal block in the daily regimen. Over 12 wk, 50% of the amount of iron in a daily regimen was sufficient for maximum hemoglobin effect. The weekly regimen provided a large part of this amount, explaining the limited difference in effect. It appears that the current international recommendation for iron supplementation in pregnancy is higher than necessary.

Original languageEnglish (US)
Pages (from-to)1392-1400
Number of pages9
JournalAmerican Journal of Clinical Nutrition
Volume76
Issue number6
StatePublished - Dec 1 2002

Fingerprint

Bangladesh
pregnant women
Pregnant Women
compliance
Iron
iron
Compliance
hemoglobin
Tablets
Hemoglobins
pregnancy
iron absorption
Pregnancy
dosage
bottles
electronics
Equipment and Supplies

Keywords

  • Bangladesh
  • Efficacy
  • Iron supplementation
  • Pregnancy
  • Trial effectiveness
  • Weekly dose frequency

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Food Science

Cite this

Ekström, E. C., Hyder, S. M. Z., Chowdhury, A. M. R., Chowdhury, S. A., Lönnerdal, B., Habicht, J. P., & Persson, L. Å. (2002). Efficacy and trial effectiveness of weekly and daily iron supplementation among pregnant women in rural Bangladesh: Disentangling the issues. American Journal of Clinical Nutrition, 76(6), 1392-1400.

Efficacy and trial effectiveness of weekly and daily iron supplementation among pregnant women in rural Bangladesh : Disentangling the issues. / Ekström, Eva Charlotte; Hyder, S. M Ziauddin; Chowdhury, A. Mushtaque R; Chowdhury, Sadia A.; Lönnerdal, Bo; Habicht, Jean Pierre; Persson, Lars Åke.

In: American Journal of Clinical Nutrition, Vol. 76, No. 6, 01.12.2002, p. 1392-1400.

Research output: Contribution to journalArticle

Ekström, EC, Hyder, SMZ, Chowdhury, AMR, Chowdhury, SA, Lönnerdal, B, Habicht, JP & Persson, LÅ 2002, 'Efficacy and trial effectiveness of weekly and daily iron supplementation among pregnant women in rural Bangladesh: Disentangling the issues', American Journal of Clinical Nutrition, vol. 76, no. 6, pp. 1392-1400.
Ekström, Eva Charlotte ; Hyder, S. M Ziauddin ; Chowdhury, A. Mushtaque R ; Chowdhury, Sadia A. ; Lönnerdal, Bo ; Habicht, Jean Pierre ; Persson, Lars Åke. / Efficacy and trial effectiveness of weekly and daily iron supplementation among pregnant women in rural Bangladesh : Disentangling the issues. In: American Journal of Clinical Nutrition. 2002 ; Vol. 76, No. 6. pp. 1392-1400.
@article{a77b9176b98745e4a728aa2a540ae889,
title = "Efficacy and trial effectiveness of weekly and daily iron supplementation among pregnant women in rural Bangladesh: Disentangling the issues",
abstract = "Background: According to our current understanding, iron absorption with weekly iron supplements is not higher than that with daily supplements (ie, there is no mucosal block). However, community-based trials have repeatedly shown that a weekly regimen is as effective as a daily one. Furthermore, when differences in absorption are found, they are commonly smaller than would be expected on the basis of differences in the amount of iron provided. The possibility of differential compliance between the regimens needs to be evaluated to explain these findings. Objective: Taking compliance into account, we compared the efficacy and trial effectiveness of weekly and daily iron supplementation during pregnancy. Design: In Bangladesh, 50 antenatal centers were randomly assigned to prescribe either 2 doses of 60 mg Fe once weekly or 1 dose of 60 mg Fe/d. Compliance was monitored by using a pill bottle equipped with an electronic counting device. Hemoglobin concentrations were measured at baseline and after 4, 8, and 12 wk of supplementation. Results: There was no differential effect per iron tablet between weekly and daily regimens. A 12-wk daily regimen (68{\%} compliance) produced a small but significantly greater hemoglobin response than did the weekly regimen (104{\%} compliance). The first 20 tablets consumed produced most of the effect; after 40 tablets, there was no further response. Conclusions: There was no evidence of a mucosal block in the daily regimen. Over 12 wk, 50{\%} of the amount of iron in a daily regimen was sufficient for maximum hemoglobin effect. The weekly regimen provided a large part of this amount, explaining the limited difference in effect. It appears that the current international recommendation for iron supplementation in pregnancy is higher than necessary.",
keywords = "Bangladesh, Efficacy, Iron supplementation, Pregnancy, Trial effectiveness, Weekly dose frequency",
author = "Ekstr{\"o}m, {Eva Charlotte} and Hyder, {S. M Ziauddin} and Chowdhury, {A. Mushtaque R} and Chowdhury, {Sadia A.} and Bo L{\"o}nnerdal and Habicht, {Jean Pierre} and Persson, {Lars {\AA}ke}",
year = "2002",
month = "12",
day = "1",
language = "English (US)",
volume = "76",
pages = "1392--1400",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "6",

}

TY - JOUR

T1 - Efficacy and trial effectiveness of weekly and daily iron supplementation among pregnant women in rural Bangladesh

T2 - Disentangling the issues

AU - Ekström, Eva Charlotte

AU - Hyder, S. M Ziauddin

AU - Chowdhury, A. Mushtaque R

AU - Chowdhury, Sadia A.

AU - Lönnerdal, Bo

AU - Habicht, Jean Pierre

AU - Persson, Lars Åke

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Background: According to our current understanding, iron absorption with weekly iron supplements is not higher than that with daily supplements (ie, there is no mucosal block). However, community-based trials have repeatedly shown that a weekly regimen is as effective as a daily one. Furthermore, when differences in absorption are found, they are commonly smaller than would be expected on the basis of differences in the amount of iron provided. The possibility of differential compliance between the regimens needs to be evaluated to explain these findings. Objective: Taking compliance into account, we compared the efficacy and trial effectiveness of weekly and daily iron supplementation during pregnancy. Design: In Bangladesh, 50 antenatal centers were randomly assigned to prescribe either 2 doses of 60 mg Fe once weekly or 1 dose of 60 mg Fe/d. Compliance was monitored by using a pill bottle equipped with an electronic counting device. Hemoglobin concentrations were measured at baseline and after 4, 8, and 12 wk of supplementation. Results: There was no differential effect per iron tablet between weekly and daily regimens. A 12-wk daily regimen (68% compliance) produced a small but significantly greater hemoglobin response than did the weekly regimen (104% compliance). The first 20 tablets consumed produced most of the effect; after 40 tablets, there was no further response. Conclusions: There was no evidence of a mucosal block in the daily regimen. Over 12 wk, 50% of the amount of iron in a daily regimen was sufficient for maximum hemoglobin effect. The weekly regimen provided a large part of this amount, explaining the limited difference in effect. It appears that the current international recommendation for iron supplementation in pregnancy is higher than necessary.

AB - Background: According to our current understanding, iron absorption with weekly iron supplements is not higher than that with daily supplements (ie, there is no mucosal block). However, community-based trials have repeatedly shown that a weekly regimen is as effective as a daily one. Furthermore, when differences in absorption are found, they are commonly smaller than would be expected on the basis of differences in the amount of iron provided. The possibility of differential compliance between the regimens needs to be evaluated to explain these findings. Objective: Taking compliance into account, we compared the efficacy and trial effectiveness of weekly and daily iron supplementation during pregnancy. Design: In Bangladesh, 50 antenatal centers were randomly assigned to prescribe either 2 doses of 60 mg Fe once weekly or 1 dose of 60 mg Fe/d. Compliance was monitored by using a pill bottle equipped with an electronic counting device. Hemoglobin concentrations were measured at baseline and after 4, 8, and 12 wk of supplementation. Results: There was no differential effect per iron tablet between weekly and daily regimens. A 12-wk daily regimen (68% compliance) produced a small but significantly greater hemoglobin response than did the weekly regimen (104% compliance). The first 20 tablets consumed produced most of the effect; after 40 tablets, there was no further response. Conclusions: There was no evidence of a mucosal block in the daily regimen. Over 12 wk, 50% of the amount of iron in a daily regimen was sufficient for maximum hemoglobin effect. The weekly regimen provided a large part of this amount, explaining the limited difference in effect. It appears that the current international recommendation for iron supplementation in pregnancy is higher than necessary.

KW - Bangladesh

KW - Efficacy

KW - Iron supplementation

KW - Pregnancy

KW - Trial effectiveness

KW - Weekly dose frequency

UR - http://www.scopus.com/inward/record.url?scp=0036894479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036894479&partnerID=8YFLogxK

M3 - Article

C2 - 12450908

AN - SCOPUS:0036894479

VL - 76

SP - 1392

EP - 1400

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 6

ER -